Board Change • Jul 08
High number of new and inexperienced directors There are 9 new directors who have joined the board in the last 3 years. The company's board is composed of: 9 new directors. 2 experienced directors. No highly experienced directors. Non-Employee Supervisor Shan Liu is the most experienced director on the board, commencing their role in 2022. The following issues are considered to be risks according to the Simply Wall St Risk Model: Lack of board continuity. Lack of experienced directors. Tillkännagivande • Jun 30
Chengzhi Co., Ltd. to Report First Half, 2026 Results on Aug 13, 2026 Chengzhi Co., Ltd. announced that they will report first half, 2026 results on Aug 13, 2026 Tillkännagivande • Jun 09
Chengzhi Co., Ltd., Annual General Meeting, Jun 29, 2026 Chengzhi Co., Ltd., Annual General Meeting, Jun 29, 2026, at 14:00 China Standard Time. Location: 17F, Tower B, Innovation Building, Tsinghua Science and Technology Park, Beijing China Tillkännagivande • Mar 31
Chengzhi Co., Ltd. to Report Q1, 2026 Results on Apr 15, 2026 Chengzhi Co., Ltd. announced that they will report Q1, 2026 results on Apr 15, 2026 Tillkännagivande • Dec 31
Chengzhi Co., Ltd. to Report Fiscal Year 2025 Results on Apr 15, 2026 Chengzhi Co., Ltd. announced that they will report fiscal year 2025 results on Apr 15, 2026 Tillkännagivande • Sep 30
Chengzhi Co., Ltd. to Report Q3, 2025 Results on Oct 25, 2025 Chengzhi Co., Ltd. announced that they will report Q3, 2025 results on Oct 25, 2025 Tillkännagivande • Jul 02
Chengzhi Co., Ltd. to Report First Half, 2025 Results on Aug 08, 2025 Chengzhi Co., Ltd. announced that they will report first half, 2025 results on Aug 08, 2025 Tillkännagivande • Apr 18
Chengzhi Co., Ltd. Approves Cash Dividend for 2024 Chengzhi Co., Ltd. announced at its annual general meeting of 2024 held on 16 April 2025, approved the cash dividend of CNY 0.50000000 per 10 shares (tax included). Tillkännagivande • Mar 31
Chengzhi Co., Ltd. to Report Q1, 2025 Results on Apr 24, 2025 Chengzhi Co., Ltd. announced that they will report Q1, 2025 results on Apr 24, 2025 Tillkännagivande • Mar 28
Chengzhi Co., Ltd. Proposes Final Cash Dividend for 2024 Chengzhi Co., Ltd. announced on 27 March 2025 the profit distribution proposal for 2024 as follows: final cash dividend of CNY 0.50000000 per 10 shares (tax included). Tillkännagivande • Mar 27
Chengzhi Co., Ltd., Annual General Meeting, Apr 16, 2025 Chengzhi Co., Ltd., Annual General Meeting, Apr 16, 2025, at 14:00 China Standard Time. Location: 17F, Tower B, Innovation Building, Tsinghua Science and Technology Park, Beijing China Tillkännagivande • Dec 31
Chengzhi Co., Ltd. to Report Fiscal Year 2024 Results on Mar 27, 2025 Chengzhi Co., Ltd. announced that they will report fiscal year 2024 results on Mar 27, 2025 Reported Earnings • Oct 25
Third quarter 2024 earnings released: EPS: CN¥0.026 (vs CN¥0.14 in 3Q 2023) Third quarter 2024 results: EPS: CN¥0.026 (down from CN¥0.14 in 3Q 2023). Revenue: CN¥2.58b (down 26% from 3Q 2023). Net income: CN¥31.3m (down 81% from 3Q 2023). Profit margin: 1.2% (down from 4.8% in 3Q 2023). Revenue is forecast to grow 20% p.a. on average during the next 3 years, compared to a 15% growth forecast for the Chemicals industry in China. Over the last 3 years on average, the company's share price growth rate has exceeded its earnings growth rate by 47 percentage points per year, which is a significant difference in performance. Tillkännagivande • Sep 30
Chengzhi Co., Ltd. to Report Q3, 2024 Results on Oct 25, 2024 Chengzhi Co., Ltd. announced that they will report Q3, 2024 results on Oct 25, 2024 Valuation Update With 7 Day Price Move • Sep 27
Investor sentiment improves as stock rises 18% After last week's 18% share price gain to CN¥7.53, the stock trades at a forward P/E ratio of 29x. Average forward P/E is 16x in the Chemicals industry in China. Total loss to shareholders of 53% over the past three years. Reported Earnings • Jul 26
Second quarter 2024 earnings released: EPS: CN¥0.027 (vs CN¥0.017 in 2Q 2023) Second quarter 2024 results: EPS: CN¥0.027 (up from CN¥0.017 in 2Q 2023). Revenue: CN¥2.94b (down 7.7% from 2Q 2023). Net income: CN¥33.1m (up 59% from 2Q 2023). Profit margin: 1.1% (up from 0.7% in 2Q 2023). Over the last 3 years on average, the company's share price growth rate has exceeded its earnings growth rate by 53 percentage points per year, which is a significant difference in performance. Tillkännagivande • Jun 29
Chengzhi Co., Ltd. to Report First Half, 2024 Results on Jul 26, 2024 Chengzhi Co., Ltd. announced that they will report first half, 2024 results on Jul 26, 2024 Declared Dividend • May 25
Dividend reduced to CN¥0.05 Dividend of CN¥0.05 is 55% lower than last year. Ex-date: 29th May 2024 Payment date: 29th May 2024 Dividend yield will be 0.6%, which is lower than the industry average of 2.6%. Tillkännagivande • May 25
Chengzhi Co., Ltd. Announces Final Cash Dividend on A Shares for the Year 2023, Payable on 29 May 2024 Chengzhi Co., Ltd. announced final cash dividend/10 shares (tax included) of CNY 0.50000000 on A shares for the year 2023. Record date: 28 May 2024. Ex-date: 29 May 2024. Payment date: 29 May 2024. Valuation Update With 7 Day Price Move • May 10
Investor sentiment improves as stock rises 16% After last week's 16% share price gain to CN¥8.95, the stock trades at a trailing P/E ratio of 28x. Average trailing P/E is 35x in the Chemicals industry in China. Total loss to shareholders of 35% over the past three years. Reported Earnings • Apr 17
First quarter 2024 earnings released: EPS: CN¥0.13 (vs CN¥0.047 loss in 1Q 2023) First quarter 2024 results: EPS: CN¥0.13 (up from CN¥0.047 loss in 1Q 2023). Revenue: CN¥2.72b (down 19% from 1Q 2023). Net income: CN¥154.1m (up CN¥211.0m from 1Q 2023). Profit margin: 5.7% (up from net loss in 1Q 2023). Revenue is forecast to grow 17% p.a. on average during the next 2 years, compared to a 15% growth forecast for the Chemicals industry in China. Over the last 3 years on average, the company's share price growth rate has exceeded its earnings growth rate by 60 percentage points per year, which is a significant difference in performance. Tillkännagivande • Apr 05
Chengzhi Co., Ltd. Approves Cash Dividend for 2023 Chengzhi Co., Ltd. at its Annual General Meeting of 2023 held on 02 April 2024, the shareholders approved: cash dividend/10 shares (tax included): CNY 0.50000000 for the year 2023. Tillkännagivande • Mar 30
Chengzhi Co., Ltd. to Report Q1, 2024 Results on Apr 17, 2024 Chengzhi Co., Ltd. announced that they will report Q1, 2024 results on Apr 17, 2024 Tillkännagivande • Mar 14
Chengzhi Co., Ltd., Annual General Meeting, Apr 02, 2024 Chengzhi Co., Ltd., Annual General Meeting, Apr 02, 2024, at 14:00 China Standard Time. Location: 17F, Tower B, Innovation Building, TusPark, Beijing China Agenda: To consider 2023 work report of the board of directors; to 2023 work report of the supervisory committee; to 2023 annual report and its summary; to 2023 annual accounts report; to 2023 profit distribution plan; to 2023 assets write-off and provision for assets impairment; to 2024 application for comprehensive credit line to banks; to 2024 provision of guarantee for controlled subsidiaries; and to consider other matters. Reported Earnings • Mar 13
Full year 2023 earnings released: EPS: CN¥0.15 (vs CN¥0.044 in FY 2022) Full year 2023 results: EPS: CN¥0.15 (up from CN¥0.044 in FY 2022). Revenue: CN¥12.4b (up 6.0% from FY 2022). Net income: CN¥177.4m (up 236% from FY 2022). Profit margin: 1.4% (up from 0.5% in FY 2022). Revenue is forecast to grow 13% p.a. on average during the next 2 years, compared to a 18% growth forecast for the Chemicals industry in China. Over the last 3 years on average, the company's share price growth rate has exceeded its earnings growth rate by 55 percentage points per year, which is a significant difference in performance. Valuation Update With 7 Day Price Move • Feb 02
Investor sentiment deteriorates as stock falls 15% After last week's 15% share price decline to CN¥6.72, the stock trades at a forward P/E ratio of 17x. Average forward P/E is 13x in the Chemicals industry in China. Total loss to shareholders of 38% over the past three years. Tillkännagivande • Dec 30
Chengzhi Co., Ltd. to Report Fiscal Year 2023 Results on Feb 29, 2024 Chengzhi Co., Ltd. announced that they will report fiscal year 2023 results on Feb 29, 2024 New Risk • Dec 22
New major risk - Revenue and earnings growth Earnings have declined by 22% per year over the past 5 years. This is considered a major risk. Ultimately, shareholders want to see a good return on their investment and that generally comes from sharing in the company's profits. If profits are declining over an extended period, then in most cases the share price will decline over time unless the company can turn around its fortunes. A trend of falling earnings can be very difficult to turn around. If the company is well already established it may also be a sign the company has matured and is in decline. In addition, if the company pays dividends it will also likely need to reduce or cut them, striking a dual blow to total shareholder returns. Currently, the following risks have been identified for the company: Major Risk Earnings have declined by 22% per year over the past 5 years. Minor Risks Unstable dividend paying track record with dividend experiencing an annual drop of over 20% in the past. Large one-off items impacting financial results. Reported Earnings • Oct 27
Third quarter 2023 earnings released: EPS: CN¥0.14 (vs CN¥0.098 loss in 3Q 2022) Third quarter 2023 results: EPS: CN¥0.14 (up from CN¥0.098 loss in 3Q 2022). Revenue: CN¥3.47b (up 22% from 3Q 2022). Net income: CN¥166.9m (up CN¥285.3m from 3Q 2022). Profit margin: 4.8% (up from net loss in 3Q 2022). Revenue is forecast to grow 12% p.a. on average during the next 3 years, compared to a 19% growth forecast for the Chemicals industry in China. Over the last 3 years on average, earnings per share has fallen by 57% per year but the company’s share price has only fallen by 16% per year, which means it has not declined as severely as earnings. Tillkännagivande • Sep 30
Chengzhi Co., Ltd. to Report Q3, 2023 Results on Oct 27, 2023 Chengzhi Co., Ltd. announced that they will report Q3, 2023 results on Oct 27, 2023 Tillkännagivande • Jul 01
Chengzhi Co., Ltd. to Report First Half, 2023 Results on Aug 12, 2023 Chengzhi Co., Ltd. announced that they will report first half, 2023 results on Aug 12, 2023 Tillkännagivande • Jun 06
Chengzhi Co., Ltd. Announces 2022 Final Profit Distribution Plan to Be Implemented (A Shares), Payable on 09 June 2023 Chengzhi Co., Ltd. announced 2022 final profit distribution plan to be implemented (A shares) of Cash dividend/10 shares (tax included): CNY 1.10000000. Record date: 08 June 2023; Ex-date: 09 June 2023; Payment date: 09 June 2023. Reported Earnings • Mar 26
Full year 2022 earnings released: EPS: CN¥0.044 (vs CN¥0.83 in FY 2021) Full year 2022 results: EPS: CN¥0.044 (down from CN¥0.83 in FY 2021). Revenue: CN¥11.7b (down 3.8% from FY 2021). Net income: CN¥52.9m (down 95% from FY 2021). Profit margin: 0.5% (down from 8.3% in FY 2021). Over the last 3 years on average, earnings per share has increased by 6% per year but the company’s share price has fallen by 12% per year, which means it is significantly lagging earnings. Board Change • Nov 16
High number of new and inexperienced directors There are 8 new directors who have joined the board in the last 3 years. The company's board is composed of: 8 new directors. 2 experienced directors. No highly experienced directors. Independent Director Yaxiong Guo is the most experienced director on the board, commencing their role in 2017. The following issues are considered to be risks according to the Simply Wall St Risk Model: Lack of board continuity. Lack of experienced directors. Reported Earnings • Oct 29
Third quarter 2022 earnings released: CN¥0.098 loss per share (vs CN¥0.30 profit in 3Q 2021) Third quarter 2022 results: CN¥0.098 loss per share (down from CN¥0.30 profit in 3Q 2021). Revenue: CN¥2.84b (down 11% from 3Q 2021). Net loss: CN¥118.5m (down 132% from profit in 3Q 2021). Over the last 3 years on average, earnings per share has increased by 18% per year but the company’s share price has fallen by 14% per year, which means it is significantly lagging earnings. Board Change • Oct 09
High number of new and inexperienced directors There are 7 new directors who have joined the board in the last 3 years. The company's board is composed of: 7 new directors. 5 experienced directors. No highly experienced directors. Independent Director Yaxiong Guo is the most experienced director on the board, commencing their role in 2017. The following issues are considered to be risks according to the Simply Wall St Risk Model: Lack of board continuity. Lack of experienced directors. Reported Earnings • Jul 25
First half 2022 earnings released: EPS: CN¥0.12 (vs CN¥0.61 in 1H 2021) First half 2022 results: EPS: CN¥0.12 (down from CN¥0.61 in 1H 2021). Revenue: CN¥6.48b (up 1.3% from 1H 2021). Net income: CN¥149.9m (down 80% from 1H 2021). Profit margin: 2.3% (down from 12% in 1H 2021). Over the last 3 years on average, earnings per share has increased by 30% per year but the company’s share price has fallen by 12% per year, which means it is significantly lagging earnings. Buying Opportunity • Jul 23
Now 21% undervalued after recent price drop Over the last 90 days, the stock is down 4.9%. The fair value is estimated to be CN¥12.87, however this is not to be taken as a buy recommendation but rather should be used as a guide only. Revenue has grown by 29% over the last 3 years. Earnings per share has grown by 31%. Buying Opportunity • Jul 06
Now 20% undervalued after recent price drop Over the last 90 days, the stock is down 14%. The fair value is estimated to be CN¥13.39, however this is not to be taken as a buy recommendation but rather should be used as a guide only. Revenue has grown by 29% over the last 3 years. Earnings per share has grown by 31%. Revenue is forecast to grow by 29% in 2 years. Earnings is forecast to decline by 12% in the next 2 years. Buying Opportunity • Jun 10
Now 20% undervalued after recent price drop Over the last 90 days, the stock is down 16%. The fair value is estimated to be CN¥13.05, however this is not to be taken as a buy recommendation but rather should be used as a guide only. Revenue has grown by 29% over the last 3 years. Earnings per share has grown by 31%. Revenue is forecast to grow by 29% in 2 years. Earnings is forecast to decline by 12% in the next 2 years. Reported Earnings • Apr 27
First quarter 2022 earnings released: EPS: CN¥0.12 (vs CN¥0.27 in 1Q 2021) First quarter 2022 results: EPS: CN¥0.12 (down from CN¥0.27 in 1Q 2021). Revenue: CN¥3.36b (up 12% from 1Q 2021). Net income: CN¥146.4m (down 55% from 1Q 2021). Profit margin: 4.4% (down from 11% in 1Q 2021). The decrease in margin was driven by higher expenses. Over the last 3 years on average, earnings per share has increased by 31% per year but the company’s share price has fallen by 26% per year, which means it is significantly lagging earnings. Reported Earnings • Oct 20
Third quarter 2021 earnings released: EPS CN¥0.30 (vs CN¥0.20 in 3Q 2020) The company reported a strong third quarter result with improved earnings, revenues and profit margins. Third quarter 2021 results: Revenue: CN¥3.17b (up 17% from 3Q 2020). Net income: CN¥365.7m (up 49% from 3Q 2020). Profit margin: 12% (up from 9.1% in 3Q 2020). The increase in margin was driven by higher revenue. Over the last 3 years on average, earnings per share has increased by 14% per year but the company’s share price has only increased by 7% per year, which means it is significantly lagging earnings growth. Valuation Update With 7 Day Price Move • Aug 04
Investor sentiment improved over the past week After last week's 24% share price gain to CN¥17.47, the stock trades at a forward P/E ratio of 14x. Average forward P/E is 19x in the Chemicals industry in China. Total returns to shareholders of 29% over the past three years. Reported Earnings • Jul 27
Second quarter 2021 earnings released: EPS CN¥0.34 (vs CN¥0.042 loss in 2Q 2020) The company reported a strong second quarter result with improved earnings, revenues and profit margins. Second quarter 2021 results: Revenue: CN¥3.41b (up 73% from 2Q 2020). Net income: CN¥416.4m (up CN¥467.2m from 2Q 2020). Profit margin: 12% (up from net loss in 2Q 2020). The move to profitability was driven by higher revenue. Over the last 3 years on average, earnings per share has fallen by 6% per year but the company’s share price has increased by 2% per year, which means it is well ahead of earnings. Reported Earnings • Apr 16
First quarter 2021 earnings released: EPS CN¥0.27 (vs CN¥0.13 loss in 1Q 2020) The company reported a strong first quarter result with improved earnings, revenues and profit margins. First quarter 2021 results: Revenue: CN¥2.99b (up 49% from 1Q 2020). Net income: CN¥322.3m (up CN¥477.8m from 1Q 2020). Profit margin: 11% (up from net loss in 1Q 2020). The move to profitability was driven by higher revenue. Over the last 3 years on average, earnings per share has fallen by 30% per year but the company’s share price has only fallen by 4% per year, which means it has not declined as severely as earnings. Analyst Estimate Surprise Post Earnings • Mar 05
Revenue beats expectations Revenue exceeded analyst estimates by 25%. Over the next year, revenue is expected to shrink by 14% compared to a 51% growth forecast for the Chemicals industry in China. Reported Earnings • Mar 05
Full year 2020 earnings released: EPS CN¥0.29 (vs CN¥0.36 in FY 2019) The company reported a mediocre full year result with weaker earnings and profit margins, although revenues improved. Full year 2020 results: Revenue: CN¥9.73b (up 41% from FY 2019). Net income: CN¥355.1m (down 20% from FY 2019). Profit margin: 3.6% (down from 6.4% in FY 2019). The decrease in margin was driven by higher expenses. Over the last 3 years on average, earnings per share has fallen by 44% per year but the company’s share price has only fallen by 5% per year, which means it has not declined as severely as earnings. Is New 90 Day High Low • Mar 05
New 90-day high: CN¥14.38 The company is up 1.0% from its price of CN¥14.27 on 04 December 2020. The Chinese market is also up 1.0% over the last 90 days, indicating the company’s price trend is similar to the market over that time. However, it underperformed the Chemicals industry, which is up 11% over the same period. Is New 90 Day High Low • Jan 27
New 90-day low: CN¥11.00 The company is down 15% from its price of CN¥12.95 on 30 October 2020. The Chinese market is up 9.0% over the last 90 days, indicating the company underperformed over that time. It also underperformed the Chemicals industry, which is up 21% over the same period. Is New 90 Day High Low • Jan 11
New 90-day low: CN¥11.21 The company is down 15% from its price of CN¥13.24 on 14 October 2020. The Chinese market is up 5.0% over the last 90 days, indicating the company underperformed over that time. It also underperformed the Chemicals industry, which is up 12% over the same period. Is New 90 Day High Low • Dec 25
New 90-day low: CN¥12.78 The company is down 1.0% from its price of CN¥12.94 on 25 September 2020. The Chinese market is up 5.0% over the last 90 days, indicating the company underperformed over that time. It also underperformed the Chemicals industry, which is up 10.0% over the same period. 
